RenovoRx, Inc. (RNXT) Files Form 4 with SEC on December 8, 2025
RenovoRx, Inc. (RNXT) submitted a Form 4 filing to the SEC on December 8, 2025.
4
Stoke Therapeutics (STOK) CEO Sells 10,000 Shares Under Pre-Arranged Plan
Stoke Therapeutics CEO Edward M. Kaye sold 10,000 shares for $150,000 total, according to an SEC Form 4 filing.